192 related articles for article (PubMed ID: 30178997)
1. Sialic Acid-Functionalized pH-Triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma.
Xu XL; Lu KJ; Zhu ML; Du YL; Zhu YF; Zhang NN; Wang XJ; Kang XQ; Xu DM; Ying XY; Yu RS; Lu CY; Ji JS; You J; Du YZ
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31903-31914. PubMed ID: 30178997
[TBL] [Abstract][Full Text] [Related]
2. Sialic-Acid-Anchored Micelles: A Hierarchical Targeting Device for Enhanced Tumor Tissue Accumulation and Cellular Internalization.
Zhu ML; Xu XL; Wang XJ; Zhang NN; Lu KJ; Qi J; Jin FY; Liu D; Du YZ
Mol Pharm; 2018 Sep; 15(9):4235-4246. PubMed ID: 30110551
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
4. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
5. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.
Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ
Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540
[TBL] [Abstract][Full Text] [Related]
6. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
7. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
8. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.
Qu C; Li J; Zhou Y; Yang S; Chen W; Li F; You B; Liu Y; Zhang X
AAPS J; 2018 Feb; 20(2):34. PubMed ID: 29476273
[TBL] [Abstract][Full Text] [Related]
9. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
[TBL] [Abstract][Full Text] [Related]
10. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression.
Liu X; Li Y; Tan X; Rao R; Ren Y; Liu L; Yang X; Liu W
Biomaterials; 2018 Mar; 157():136-148. PubMed ID: 29268144
[TBL] [Abstract][Full Text] [Related]
12. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
Wu Z; Chen B; Gan Z; Chen F; Luo X
Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
[TBL] [Abstract][Full Text] [Related]
14. Folate-functionalized polymeric micelles based on biodegradable PEG-PDLLA as a hepatic carcinoma-targeting delivery system.
Niu C; Sun Q; Zhou J; Cheng D; Hong G
Asian Pac J Cancer Prev; 2011; 12(8):1995-9. PubMed ID: 22292640
[TBL] [Abstract][Full Text] [Related]
15. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
[TBL] [Abstract][Full Text] [Related]
16. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
[TBL] [Abstract][Full Text] [Related]
17. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
18. Acid-sensitive polymeric vector targeting to hepatocarcinoma cells via glycyrrhetinic acid receptor-mediated endocytosis.
Yan T; Cheng J; Liu Z; Cheng F; Wei X; Huang Y; He J
Mater Sci Eng C Mater Biol Appl; 2018 Jun; 87():32-40. PubMed ID: 29549947
[TBL] [Abstract][Full Text] [Related]
19. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
